Procter & Gamble Company (PG) Financials
Key financial figures for Procter & Gamble Company (Q4 2026).
P&G posted flat Q4 organic sales growth (0%) on a 2% net sales increase to $21.2B, with core EPS down 3% to $1.43 as restructuring costs and unfavorable mix weighed on margins, while guiding FY2027 organic sales and core EPS growth of 1-3% and 0-3% respectively. Net sales rose 2% reported to $21.2B in Q4 FY2026, but organic sales growth was flat (0%), decelerating sharply from Q3's +3%. Core EPS fell 3% to $1.43 (GAAP diluted EPS fell 15% to $1.26, weighed by ~90 bps of non-core restructuring charges); core gross margin was roughly flat at 49.1%. Segment picture was mixed: Beauty led with +4% organic sales growth ($3.98B net sales), while Health Care (-1%) and Baby, Feminine & Family Care (-2%) declined organically; Fabric & Home Care and Grooming were roughly flat. On the outlook: FY2027: all-in sales growth of +1% to +3% and organic sales growth of +1% to +3% (includes a 30-50 bps headwind from brand/product-form/go-to-market discontinuations); GAAP diluted EPS growth of +1% to +5% versus FY2026's $6.62 (includes $0.13-$0.17/share of expected non-core restructuring charges); core EPS growth of in-line to +3% versus FY2026's $6.89, implying $6.89-$7.11/share with a $7.00 midpoint; management flagged an estimated $0.56/share (~8-point) core EPS headwind from higher commodities/energy/transportation costs (~$1B after-tax), higher net interest expense ($150M after-tax), lower non-operating income ($150M after-tax), and unfavorable FX ($50M after-tax). Figures are for Q4 FY2026, as Procter & Gamble Company reported them.
- Revenue
- $21.2B
- Net Income
- $3.1B
- EPS
- $1.28
- Total Assets
- $126.5B
- Operating Cash Flow
- $5.1B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q4 FY2026 | $21.2B | $3.0B | $1.26 | 18.63% | $4.9B |
| Q3 FY2026 | $21.2B | $4.0B | $1.63 | 21.55% | $3.0B |
| Q2 FY2026 | $22.2B | $4.3B | $1.78 | 24.16% | $3.8B |
| Q1 FY2026 | $22.4B | $4.8B | $1.95 | 26.16% | $4.2B |
| Q4 FY2025 | $20.9B | $3.6B | $1.48 | 20.85% | $4.0B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $87.0B | $16.0B | $6.62 | 22.69% | $15.9B |
| FY2025 | $84.3B | $16.0B | $6.51 | 24.26% | $14.0B |
| FY2024 | $84.0B | $14.9B | $6.02 | 22.07% | $16.5B |
Frequently asked questions
What was Procter & Gamble Company's revenue last quarter?
Procter & Gamble Company reported revenue of $21.20 billion for Q4 FY2026, up 1.5% from the same period a year earlier.
Is Procter & Gamble Company profitable?
Yes. Procter & Gamble Company reported net income of $3.00 billion for Q4 FY2026, a net margin of 14.13% on revenue.
How has Procter & Gamble Company's margin trended?
Operating margin was 18.63% in Q4 FY2026, compared with 20.85% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
When does Procter & Gamble Company report next?
Procter & Gamble Company is scheduled to report results on 2026-10-22. The company has confirmed that date.
Full income statement, balance sheet and cash flow for Procter & Gamble Company on SentiSense, with up to forty quarters and twenty fiscal years of history.